Hydroxyls on the B ring and gallic acyl are essential for catechins to restrain ADP-induced thrombosis

Yani Pan1, Xinyu Feng1,2, Su Zhou1,2

  • 1Tea Research Institute, Zhejiang University, Hangzhou 310058, China. 0619363@zju.edu.cn.

Food & Function
|December 23, 2022
PubMed

Insights

Tea compounds called catechins can prevent blood clots by inhibiting platelet aggregation. Specific structures, like gallic acyl groups, are key to this antithrombotic effect, offering potential for cardiovascular disease prevention.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cardiovascular Research

Background:

  • Platelet hyperactivation is linked to cardiovascular and cerebrovascular diseases.
  • Long-term tea consumption is associated with reduced cardiovascular disease risk.
  • Catechins, particularly epigallocatechin gallate (EGCG), show potential in alleviating thrombosis by inhibiting platelet aggregation.

Purpose of the Study:

  • To investigate the structure-activity relationship of six typical catechins concerning their anti-platelet aggregation effects.
  • To explore the underlying mechanisms of how different catechin structures inhibit platelet activation.
  • To identify key functional groups responsible for the antithrombotic activity of catechins.

Main Methods:

  • Construction of platelet activation models using various inducers.
  • Utilized techniques including flow cytometry, immunoblotting, and cell spreading assays.
  • Evaluated the inhibitory effects of catechins with distinct structural features on platelet aggregation.

Main Results:

  • Ester catechins demonstrated inhibition of adenosine diphosphate (ADP)-induced platelet aggregation.
  • Epigallocatechin (EGC), a non-ester catechin with three hydroxyls on the B ring, also effectively inhibited platelet aggregation.
  • Gallic acyl groups on the C ring and three hydroxyls on the B ring were identified as crucial functional groups for antithrombotic effects, with gallic acyl showing a stronger impact than hydroxyl groups.

Conclusions:

  • Specific structural features of catechins, namely gallic acyl on the C ring and multiple hydroxyls on the B ring, are critical for their ability to inhibit platelet aggregation.
  • The gallic acyl moiety exhibits a more potent effect on platelet inhibition compared to hydroxyl groups.
  • These findings elucidate the structure-activity relationship of catechins, providing insights into their therapeutic potential for cardiovascular diseases.

Related Concept Videos

Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.3K
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids02:04

Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids

Diols are compounds with two hydroxyl groups. In addition to syn dihydroxylation, diols can also be synthesized through the process of anti dihydroxylation. The process involves treating an alkene with a peroxycarboxylic acid to form an epoxide. Epoxides are highly strained three-membered rings with oxygen and two carbons occupying the corners of an equilateral triangle. This step is followed by ring-opening of the epoxide in the presence of an aqueous acid to give a trans diol.
6.0K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.2K
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH301:11

orthopara-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3

All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
6.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.8K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K